DR Horton: US housebuilder that's piling up profits

US housebuilder DR Horton’s stock rests on firm foundations and looks cheap. Matthew Partridge looks at the best way to play it.

A D.R. Horton home under construction
DR Horton almost doubled sales between 2015 and 2020
(Image credit: © Mike Fuentes/Bloomberg via Getty Images)

Despite the ongoing pandemic the US stockmarket continues to boom. As a result, valuations are at record levels, with the benchmark S&P 500 index now trading on a trailing price/earnings (p/e) ratio of 30. While this is partly due to the fact that earnings have been depressed by the pandemic, even if you compare it with predicted profits the market still looks pricey.

Edward Yardeni of Yardeni Research estimates that it is on a forward p/e of 22, the highest level since 2001 and nearly double the earnings multiple it was trading at a decade ago. It is, in short, very difficult to find shares that look priced at bargain levels.

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up
Latest Videos FromMoneyWeek
Explore More
Dr Matthew Partridge
MoneyWeek Shares editor